Rivaroxaban 10 MG

Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty

Rivaroxaban in Idiopathic Membranous Nephropathy

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa

COVID-19 Antithrombotic Rivaroxaban Evaluation

Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial

Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients

Rivaroxaban or Aspirin for Biological Aortic Prosthesis

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

PK of Rivaroxaban in Bariatric Patients - Extension

Rivaroxaban in Bariatric Surgery

Dose-finding of Rivaroxaban in Hemodialysis